Paul Secrist
2021
In 2021, Paul Secrist earned a total compensation of $1.1M as Chief Scientific Officer at Cyteir Therapeutics, a 113% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $149,916 |
|---|---|
| Option Awards | $556,815 |
| Salary | $385,105 |
| Total | $1,091,836 |
Secrist received $556.8K in option awards, accounting for 51% of the total pay in 2021.
Secrist also received $149.9K in non-equity incentive plan and $385.1K in salary.
Rankings
In 2021, Paul Secrist's compensation ranked 8,491st out of 12,415 executives tracked by ExecPay. In other words, Secrist earned more than 31.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,491 out of 12,415 | 32nd |
Division Manufacturing | 3,764 out of 5,508 | 32nd |
Major group Chemicals And Allied Products | 1,668 out of 2,378 | 30th |
Industry group Drugs | 1,485 out of 2,099 | 29th |
Industry Pharmaceutical Preparations | 1,106 out of 1,549 | 29th |
Source: SEC filing on April 29, 2022.
Secrist's colleagues
We found two more compensation records of executives who worked with Paul Secrist at Cyteir Therapeutics in 2021.